Linda D. Gillam, MD, FACC, FAHA, FASE

• Professor of Clinical Medicine
• Columbia University
• College of Physicians & Surgeons
• Medical Director, Cardiac Valve Program
• Department of Medicine
• Columbia University Medical Center
• New York, New York

Side effects: Flushing 97140 treatment code buy meclizine 25 mg with amex, chest pain or tightness medications side effects prescription drugs effective 25 mg meclizine, brief periods of asystole or bradycardia medications ok during pregnancy cheap meclizine 25 mg without prescription, ventricular ectopy symptoms nausea headache purchase generic meclizine canada. Amiodarone (Cordarone Indications: Recurrent hemodynamically unstable ventricular tachycardia medicine woman dr quinn order meclizine 25 mg amex. Appendix E the On-Call Fonnulary Second drug (after epinephrine or vasopressin) for asystole or bradycardic pulseless electrical activity. Side effects: Dryness of the mouth, blurred vision, photophobia tachycardia, anhidrosis, difficulty in micturition and occasional hypersensitivity reactions. May repeat every 3 to 5 minutes (if asystole persists) to a maximum of3 doses (3 mg). Beta Blockers (See Beta Adrenergic Blockers Dopamine (Dobutrsx (Sse Adrenergic Drugs for Cardiac Events Procainamide (Pronestyl, Procan Indications: Atrial and ventricular tachydysrhythmias. Reduces the maximum rate of depolarization in atrial and ventricular conducting tissue. Alternatively, for refractory ventricular fibrillation or ventricular tachycardia, 100 mg intravenous push doses every 5 minutes up to a maximum doseofl g. Actions: Competitively inhibit the activation of plasminogen and, at high doses, noncompetitively inhibit plasmin. Comments: the marketing of aprotinin (Trasylol) was suspended in November 2007 after a report of an increased risk of death after the use of this drug. Local treatment is generally recommended for reducing the likelihood of the emergence of azole-resistant organisms. Actions: Bind to sterols in cell membranes, increasing their permeability with the loss of a variety of essential small molecules. Actions: Thrombi are formed as a result of platelets adhering to damaged luminal surfaces of arteries. Platelets are activated by a variety of stimuli, including the prostacyclin-thromboxane pathways, and adhere to one another under the influence of fibrinogen and the von Willebrand factor to initiate clot formation. These factors bind to activated glycoprotein lib/ lila receptors on the platelet surface. Intense pharmaceutical development is addressing other potential sites that influence platelet function; thus, an ideal agent is yet to be found. Onset of action is delayed: beneficial effect not seen until after 2 weeks arterial stenting of therapy. No longer available in the United States; its use has been supplanted by the newer inhibitors. Drug Trade Name D05age Clinical Use Comments Not recommended for acute coronary syndromes Dosage adjustment required for patients with renal insufficiency Dosage adjustment required for patients with renal insufficiency Abciximab ReoPro 0. Generally, three different drugs from at least two different classes are used in combination. Because they are always used in combination, it can be difficult to identify the putative component. Ritonavir and cobicistat inhibit certain hepatic enzymes that metabolize some antiretroviral drugs, therefore boosting the drug concentrations achieved. Severe effects are common including lipodystrophy, hyperglycemia, hypertTiglyceridemia, and hypercholesterolemia. The protease inhibitors inteifere with the metabolism ofmany drugs including antiplatelet drugs, anticoagulants, and anticonvulsants. Lorazepam is useful to control the combative patient (but not indicated for delirium tremens). Appendix E the On-Call Fonnulary Alprazolam is the most common benzodiazepine misused as a recreational drug followed by clonazepam, lorazepam, and diazepam. Side effects: Respiratory depression, sedation, dizziness, cognitive impairment partic:ularly in elderly patients. Onset of Action After Elimination %-Life (h) 10-20 Dose Range 1herapeutic Use Drug Alprazolam Trade Name Xanax Oral Dose (h) 1-2 Clonaz- Klonopin 1-4 epam 20-50 Diazepam Valium 1-1. Actions: An anticholinergic (antimuscarinic) agent with antihistaminic and local anesthetic properties. Side effects: Tachycardia, dhziness, dry mouth, mydriasis, urinary hesitancy or retention. Actions: Competitive antagonism of ~-adrenergic receptors in the vascular smooth muscle and the heart and bronchiSome act predominantly on cardiac beta receptors-cardioselective agents. Some have additional alpha adrenergic blocking activity that is useful in blocking unopposed alpha activity, hence providing arteriolar vasodilation. Some have intrinsic beta agonist activity that is useful in preventing excessive bradycardia with sustained beta-blocker therapy. Comments: It is usually useful to start with a low dosage and increase as required, because individual responses vary considerably. Agents Specifically Indicated for Cardiac Arrhythmias Drug Esmolol Trade Name Brevibloc Activity Cardioselective Usual Dosage 0. Hypertension and pulmonary edema or myocardial ischemia: 1-3 mgbyslowiV push, repeating every 2-5 min to a total of5 mg. Comments: Onset: oral ingestion, in 6 to 10 hours; rectal administration, in 15 to 60 minutes. May worsen orthostatic hypotension, weakness, and incoordination in elderly patients. Bismuth Subsslicylate (Pepto-Bismol Antibacterial, Anti-inflammatory Indications: Peptic ulcer disease, diarrhea. Actions: Acts locally at the ulcer site to promote healing of gastric and duodenal ulcers; has antibacterial activity, including against Helicobacter pylori. Appendix E the On-Call Fonnulary Calcitonin Salmon (Salcatonin, Caltine Hypercalcemia Treatment Indications: Hypercalcemia of neoplastic disease, multiple myeloma, primary hyperparathyroidism. The dihydropyridines are often used to reduce systemic vascular resistance and arterial pressure, but they are not used to treat angina (with the exception of amlodipine, which carries an indication to treat chronic stable angina, as well as vasospastic angina) because the vasodilation and hypotension can lead to reflex tachycardia. Side effects: Hypotension, flushing, dizziness, constipation, headaches, peripheral edema, bradycardia. Nimodipine Nimotop Appendix E the On-Call Fonnulary Dihydropyridines-ronfd Drug Trade Name Dosage 8. Side effects: Administration of Ca2+ to patients taking digoxin may precipitate ventricular dysrhythmias because of the combined effects of digoxin and Ca2+. Comments: Note that the chloride is three times as potent as the gluconate: 10 mL of 10% calcium chloride= 1 g = 270 mg Ca = 13. Actions: Releases and depletes substance P from sensory neurons, rendering the skin insensitive to pain. Side effects: An extract of jalapefto (Mexican red) peppers that stings and burns on application. Comments: Burns mucous membranes; therefore, care must be taken to wash hands after capsaicin is applied. Actions: Bind to penicillin-binding proteins of cell walls of susceptible bacteria, causing impaired cell wall synthesis and cell lysis. Comments: Should be reserved for use against severe systemic infections caused by mixed organisms that are resistant to antibacterials with a narrower spectrum of activity. Cilastatin, which is combined in some products, has no antibacterial action but prevents the metabolism of carbapenem by dehydropeptidase in the proximal renal tubular cells and therefore decreases the rate of excretion. Reduce dosage or dose frequency for patients with renal impairment Meropenem Merrem ·see Table D. Sepsis caused by infections with Escherichia coli, indolepositive Proteus organisms, and Providencia stuartii (third-generation cephalosporin with an aminoglycoside). Meningitis, epiglottitis, or other serious infection due to Haemophilus influenzae (third-generation cephalosporin with vancomycin and with or without rifampin). Hospitalacquired pneumonia (third-generation cephalosporin with a macrolide or a fluoroquinolone). Klebsiella pneumoniae pneumonia (third-generation cephalosporin with an aminoglycoside). Actions: Like other P-lactam antibiotics, cephalosporins bind to bacterial cell membrane penicillin-binding proteins, thus inhibiting cell wall synthesis and causing cell lysis. They were originally classified as generations on the basis of their in vitro activities against gram-negative organisms. With the expanding of this spectrum through successive generations, activity against gram-positive aerobes is weakened Side effects: Diarrhea, allergic reactions, false-positive glycosuria Clinitest results. About 8% of patients allergic to penicillins have an allergic reaction to first- and second-generation cephalosporins; the overall incidence of allergic reactions to cephalosporins is 4%. This is less likely with third-generation drugs, probably because of the interference with binding caused by the bulky side chains. Comments: Cephalosporins, particularly the third-, fourth-, and advanced-generation parenteral preparations, are expensive. More advanced-generation drugs are effective against methicillin-resistant staphylococci. Appendix E the On-Call Formulary Dosage: Dosages and dose intervals vary among products and may have to be altered in the presence of renal impairment (see Table Cl, page 416). First Generation Spectrum: Gram-positive bacteria including penicillinase-producing staphylococci. Drug Trade Name Oral Parenteral Preparation Preparation Cefadroxil Cefazolin Cephalexin Cephradine Duricef Yes Ancef, Kefzol Ketlex and others Yes Velosef Yes Yes Yes Second Generation Spectrum: Gram-positive bacteria including penicillinase-producing staphylococci. Drug Trade Name Oral Parenteral Preparation Preparation Yes Yes Yes Yes Yes Yes Yes Yes Yes Cefditoren Ceftibuten Cefixime Cefoperazone Cefotaxime Cefpodoxime Ceftazidime Ceftizoxime Ceftriaxone Pivoxil Cedax Suprax Cefobid Claforan Proxetil Fortaz, Ceptaz, Tazicef, Tazidime Cefizox Rocephin Appendix E the On-Call Fonnulary Fourth Generation Spectrum: Effective against a wide range of gram-positive and gramnegative bacteria. Drug Ceftaroline Ceftobiprole Trade Name Teflaro Zevtera Oral Preparation Parenteral Preparation Yes Yes Chloral Hydrate (Noctec and Others Hypnotic Indications: Insomnia. Chlorpropamide (Diabinese Oral Hypoglycemic Agent Indications: Type 2 diabetes mellitus. Actions: Sulfonylurea stimulates insulin secretion and increases the effect of insulin on the liver to increase gluconeogenesis and on muscle to increase glucose use. Side effects: Hypoglycemia, rash, blood dyscrasias, jaundice, hyponatremia, edema. Comments: Has a long duration of action (20 to 60 hours) and is cleared largely by the kidneys. Hypoglycemic reactions may be prolonged in elderly patients and in patients with renal impairment. Citrovorum Fat:tor (Leucovorin Folic Acid Derivative Indications: Folate deficiency. Appendix E the On-Call Formulary Actions: A metabolite offolic acid required as a coenzyme for nucleic acid synthesis. Comments: Should not be used to treat vitamin B12 deficiency anemia, because the anemia may respond, whereas neurologic sequelae progress. Clindamycin (Dalacin) Antibiotic Indications: Serious anaerobic infections with organisms arising in the abdomen or pelvis. Actions: A sulfone that, like the sulfonamides, competes with para-aminobenzoic acid for incorporation into folic acid. Comments: Most often used in prevention but can be added to trimethoprim-sulfamethoxazole in the treatment of P. Daptomycin (Cubicin) A Lipopeptide Antibiotic Indications: Complicated skin and skin structure infections caused by susceptible strains of the Staphylococcus aureus (including methicillin-resistant strains), Streptococcus pyogenes and Streptococcus agalactiae. Actions: Daptomycin is bactericidal against gram-positive bacteria only acting by disrupting the cell membrane. Side effects: Nausea, vomiting, diarrhea, injection site reactions, hypersensitivity reactions. Comments: Because daptomycin activity is inhibited in the presence of pulmonary surfactant, it is not indicated for use in pneumonia. Side effects: Epigastric burning, nausea, vomiting, phototoxiclty, polyuria, and polydipsia. Comments: Less useful as an antibacterial than doxycycline or minocycline because of its incomplete absorption and its renal effects. Actions: A synthetic analog of antidiuretic hormone with identical actions on water reabsorption in the renal tubule. It may also have a direct effect on the vessel wall, decreasing bleeding at an injury site. Side effects: Facial flushing, tachycardia, mild hypotension, water retention, headaches, nausea, abdominal pain, allergic reactions. Should not be administered to patients with severe type I or type liB von Willebrand disease because such patients are less likely to respond and severe thrombocytopenia may develop. Comments: 80% renally excreted; therefore, dosage must be reduced in patients with renal impairment and in elderly patients. Should not be administered to patients with hypokalemia, which can predispose to digitalis-induced arrhythmias. Actions: Block Na+ and Cl- reabsorption in the cortical diluting segment of the loop of Henle. Side effects: Electrolyte depletion, hyperuricemia, hyperglycemia, hypercalcemia, pancreatitis, jaundice. Actions: Block the action of aldosterone on the renal tubules, resulting in a loss of sodium and water. Side effects: Electrolyte depletion, hyperuricemia, hyperglycemia, anorexia, nausea, vomiting, diarrhea, hearing loss. Actions: A very potent opioid analgesic with a rapid onset and short duration of action. Approximately 80 to 100 times more potent than morphine and 40 to 50 times more potent than heroin.

Oxytocin during labour and risk of severe postpartum haemorrhage: A population-based symptoms neck pain meclizine 25 mg with mastercard, cohort-nested case­control study treatment 1st degree heart block discount 25 mg meclizine with visa. Post-partum sequential occurrence of two diverse transfusion reactions (transfusion associated circulatory overload and transfusion related acute lung injury) medications janumet buy generic meclizine 25 mg online. Transfusionrelated acute lung injury and transfusion-associated circulatory overload: Mutually exclusive or coexisting entities Transfusion-related acute lung injury and transfusion-associated circulatory overload treatment 4 toilet infection generic meclizine 25 mg buy on line. Effect of umbilical vein oxytocin on puerperal blood loss and length of the third stage of labor 9 treatment issues specific to prisons meclizine 25 mg buy otc. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Prevention and management of postpartum hemorrhage: A comparison of 4 national guidelines. Carbetocin versus oxytocin for prevention of postpartum hemorrhage after vaginal delivery in high risk women. The effects of routine oxytocic administration in the management of the third stage of labour: An overview of the evidence from controlled trials. Use of intra myometrial 15-methyl prostaglandin F2 alpha to control atonic postpartum haemorrhage following vaginal delivery and failure of conventional therapy. The use of 15 methyl F2 alpha prostaglandin (Prostin 15M) for the control of postpartum hemorrhage. Management of severe postpartum hemorrhage with a prostaglandin F2 alpha analogue. Cardiovascular collapse following an overdose of prostaglandin F2 alpha: A case report. Massive blood transfusion during hospitalization for delivery in New York State, 1998­2007. Three-dimensional ultrasonography and diagnosis of placenta percreta with bladder involvement. Use of magnetic resonance imaging and ultrasound in the antenatal diagnosis of placenta accreta. Uncontrollable postpartum bleeding: A new approach to hemostasis through angiographic arterial embolization. Angiographic embolization in the management of hemorrhagic complications of pregnancy. Primary management of postpartum vulvovaginal hematomas by angiographic embolization. Transcatheter embolization of pelvic arteries as the safest method for postpartum hemorrhage. Surgical management of postpartum hemorrhage with particular reference to ligation of uterine arteries. Internal iliac artery ligation for postpartum hemorrhage: Recanalization of vessels. Surgical control of pelvic hemorrhage: Method of bilateral ovarian artery ligation. Partial ischemic necrosis of the uterus following a uterine brace compression suture. Transvaginal pressure pack for life-threatening pelvic hemorrhage secondary to placenta accreta. Maternal and perinatal complications with uterine rupture in 142,075 patients who attempted vaginal birth after cesarean delivery: A review of the literature. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. Preemptive treatment with fibrinogen concentrate for postpartum haemorrhage: Randomized controlled trial. Delayed postpartum hemorrhage resulting from uterine artery pseudoaneurysm rupture. Highintensity focused ultrasound in the treatment of postpartum hemorrhage: An animal model. Vascular malformations in the uterus: Ultrasonographic diagnosis and conservative management. In many hospitals, even those with obstetrical teaching services, there are few operative vaginal deliveries with forceps or vacuum extractors. Therefore, the opportunity to educate physicians in training in operative vaginal delivery is decreasing and seems to be becoming the lost art of operative obstetrics. Operative vaginal delivery does, however, have risks for both mother and infant just as there are also potential significant maternal risks with delivery by cesarean section. Operative vaginal delivery is no longer an elective procedure but requires an appropriate indication as well as consent. If a spontaneous vaginal delivery is imminent, no operative delivery is indicated. Therefore, the risk benefit ratio for patients who are candidates for operative vaginal delivery should be weighed against the alternative of a cesarean delivery and not a spontaneous vaginal delivery. In this era of "modern" obstetrics, with the potential maternal and fetal risks in mind, teaching residents the use of obstetric forceps has become increasingly difficult but can still be included in a complete curriculum. The forceps consisted of two branches, each about 12 inches long, having a fenestrated blade and a cephalic curve. The major innovation of these forceps was that the branches were separable and could be inserted singly; once applied to the fetal vertex, the branches were rejoined near the handles with a leather thong or a rivet. The forceps then functioned as a first-class lever, and extraction of the fetus without damage was possible. The history and genealogy of the Chamberlen family, whose members practiced midwifery in England for three generations, constitute a fascinating example of professional life and ethics in the seventeenth century. Around 1730, Hugh Chamberlen sold his family secret to Roonhuysen, a Dutch obstetrician; unfortunately, Roonhuysen purchased only a single branch of the forceps! The first publication of the "secret" in the medical literature was by Rathlaw of Holland in 1732. By the mid-eighteenth century, the form and use of the obstetric forceps had become public knowledge in England and on the Continent, and modifications of the original had begun to appear, the first of over 800 varieties of forceps that were described during the next 200 years. Most of the modifications in design or material introduced were elaborate but nonfunctional innovations. For example, in an effort to decrease the pressure of the forceps on the fetal head, Smellie (1754) recommended covering the forceps blades with leather; this suggestion was attacked almost immediately (fortunately) as "conveying humors which are infectious. In 1734, Dusée described a movable, interlocking mechanism for joining the two branches of the forceps. Levret (1744) and Pugh (1954) independently designed forceps with a pelvic curve, which facilitated traction when the fetal head was arrested at a high station in the pelvis. This solved some of the mechanical problems of the "straight" forceps, but did not eliminate all of the difficulties associated with high and midforceps operations. It remained for Tarnier (1877) to develop a type of forceps traction in which the line of pull coincided with the pelvic axis. This "axis traction" was the first substantive modification in over 100 years, and its principles still are employed today not only in technique but also in axis traction handles8,9 and in the addition of a pelvic curvature. More recently, the use of parallel or divergent (rather than crossed) forceps was recommended by Luikhart and Lauffe to minimize fetal head compression, an inevitable concomitant of traction. The "rule" of forceps is as follows: left blade, left hand, to left side of pelvis; right blade, right hand, to right side of pelvis. Regardless of their design, all forceps have the same parts: the blade, which fits around the fetal head and the maternal pelvis; the shank, which is the portion between blade and handle; and the handle, with which the instrument is manipulated. The blade has two curves: the cephalic curve permits the instrument to fit the fetal head accurately when applied to its lateral aspects; the pelvic curve adapts the instrument to the curved axis of the pelvis. The shanks may be short (as for outlet forceps) or long (for manipulation higher in the pelvis), parallel, or overlapping, and straight or with a perineal curve to facilitate axis traction. After application, in the X-type of forceps, the two blades cross and articulate with each other, the articulation being known as the "lock. They are hollow (to reduce weight), have transverse projections at their junction with the shanks, and may or may not have lateral indentations to enhance the grip. Some forceps handles have a screw mechanism to prevent inadvertent compression during traction. The multiple forceps available, their minor differences, and the reasons therefore have been described in great detail. Longer blades and separated shanks were deemed better for the grasp of a severely molded fetal head, but they distended and often tore the perineum prematurely. Overlapping shanks avoided this problem, but increased the probability of fetal head compression. Fenestrated blades permitted a good grip on the fetal head, but often left significant marks on the baby; in doing a forceps rotation, the fenestrated blades offered more opportunities for vaginal lacerations. Solid blades reduced these problems, but more frequently slipped on the vertex during difficult rotations; semifenestrated blades (indented toward the fetus, smooth toward the maternal side) were an attempt to alleviate this problem. Midforceps the biparietal diameter of the vertex has passed the plane of the pelvic inlet. This is the application of forceps when the head is engaged, but the conditions for outlet forceps have not been met. In the context of this term, any forceps delivery requiring forceps rotation regardless of the station is designated as a midforceps delivery. High forceps the application of forceps prior to the full engagement of the head is termed a "high-forceps" application. The sagittal suture has rotated into the anteroposterior diameter with the small fontanel directed toward the symphysis. Attempt at forceps delivery would require high-forceps procedure, which is absolutely contraindicated. Station: the relationship of the estimated distance, in centimeters, between the leading bony portion of the fetal head and the level of the maternal ischial spines. In classifying midforceps procedures, the level of engagement of the fetal head must be stated as precisely as possible. Engagement of the vertex occurs when the biparietal diameter has passed through the pelvic inlet and is clinically diagnosed when the leading bony portion of the fetal head is at or below the level of the ischial spines (station 0 or more). Outlet forceps: the application of forceps when (a) the scalp is visible at the introitus without separating the labia, (b) the fetal skull has reached the pelvic floor, (c) the sagittal suture is in the anteroposterior diameter or in the right or left occiput anterior or posterior position, and (d) the fetal head is at or on the perineum. There is no documented difference in perinatal outcome when deliveries involving the use of outlet forceps are compared with similar spontaneous deliveries, and there are no data to support the concept that rotating the head on the pelvic floor 45° or less increases morbidity. Forceps delivery under these conditions may be desirable to shorten the second stage of labor. Low forceps: the application of forceps when the leading point of the skull is at station +2 or more. Midforceps: the application of forceps when the head is engaged but the leading point of the skull is above station +2. Under very unusual circumstances, such as the sudden onset of severe fetal or maternal compromise, application of forceps above station +2 may be attempted while simultaneously initiating preparations for a cesarean delivery in the event that the forceps maneuver is unsuccessful. Under no circumstances, however, should forceps be applied to an unengaged presenting part or when the cervix is not completely dilated. This change in nomenclature in no way modifies the risks inherent in these procedures. On the one hand, the relatively lower risk of forceps used for traction (with rotation limited to 45° from the vertical axis), now called "low forceps," is recognized and distinguished from "true" midforceps operations. Fetal indications primarily are related to fetal compromise such as Category 3 fetal heart tracings, Category 2 fetal heart tracings not responsive to conservative measures and remote from delivery, evidence of placenta abruption and others. Maternal indications for operative vaginal delivery are more numerous, most frequently based upon failure of descent in the second stage of labor, persistent occiput posterior, or maternal disease requiring shortening of the second stage of labor. The maternal bony pelvis must be clinically adequate, with no evidence of cephalopelvic disproportion. There must be no maternal bony or soft tissue obstruction (such as tumor or placenta previa). Of equal if not greater importance are the following contraindications for the application of forceps: 1. Perhaps a checklist may be helpful at the time of the procedure and it can be added to the medical record at the conclusion of the delivery. The patient should be placed on the delivery table in lithotomy position, with her buttocks a little past the lower end of the table. She should be anesthetized, cleansed, and draped in routine fashion for an aseptic delivery. The position and station of the fetal vertex should be rechecked by vaginal examination. In an outlet forceps procedure, the presentation will be cephalic; the sagittal suture will be in the anteroposterior diameter of the maternal pelvis, or no further than 45° in either direction. The head should be visible at the introitus without separating the vulva, and the presenting part should be at station +4. The forceps blades will be applied to the fetal vertex over the parietal bones bilaterally in an occipitomental application, with the concave edges of the blades toward the occiput. The left blade will be next to the left sidewall of the pelvis, and the right blade near the right side wall, with the concave edges pointing toward the pubis. The fingers of the left hand are inserted in the right side of the vagina between the fetal head and the vaginal wall. The patient should be reexamined vaginally to be certain that nothing lies between the forceps and the fetal head, including umbilical cord, cervix, or fetal membranes. If the blades are a little off center, with one blade nearer the occiput and the other closer to the fetal face, the forceps must be unlocked and the blades repositioned. Cervical tissue between the blades and the fetal head (cervix incompletely dilated) 5. Uterine constriction ring If the foregoing criteria are satisfied, the operator may proceed to extract the head. The operator may sit on a stool and grasp the forceps with both hands, one on the handles and the other on the shanks.

Even in recent years medicine kit meclizine 25 mg order mastercard, about one out of nine cases of abruption of the placenta was associated with perinatal mortality medicine under tongue order online meclizine. In a typical case symptoms 5 days after conception buy meclizine 25 mg line, acute retroplacental separation probably derives from the rupture of maternal small vessels treatment quadratus lumborum buy meclizine 25 mg with visa. The cause of this may be due to vasospasm of the maternal vessels or could be due to thrombosis and subsequent necrosis symptoms quitting tobacco buy meclizine with mastercard. It is generally assumed that the rupture of spiral arteries results in high-pressure bleeding that eventually expands and separates the placenta from the implantation site. Abruption could also be an acute process such as after an abdominal trauma or rapid decompression of the uterus. History of abruption in a prior pregnancy significantly increases the risk in the next pregnancy. It appears that the greater the severity of the first abruption, the higher the risk of recurrence. Recurrence risk may range from less than 2%­24% in patients with two previously affected pregnancies. It is defined as bleeding from the genital tract between week 20 of the pregnancy and the onset of labor. Premature delivery and perinatal mortality rates are increased several-fold in connection with second- and third-trimester bleeding episodes. Other causes include cervical lesions, genital infections, trauma, and rarely vasa previa, vulvovaginal varicosities, and genital tumors. Nongynecologic causes such as hematuria and rectal bleeding also should be considered. Abdominal trauma and motor vehicle accidents could result in a force sufficient to shear the placenta from its attachment to the uterine wall. Placental abruption is a risk of prenatal procedures such as external cephalic version and cordocentesis. Sudden decompression could also result in an abruption, as in the case of a multifetal pregnancy after the delivery of the first twin. Similarly, the decompression that accompanies spontaneous or artificial rupture of the membranes, particularly in patients with polyhydramnios, may also lead to abruption. When infection is present in the setting of ruptured membranes, the risk increases more than ninefold. Commonly associated signs and symptoms are back pain, vaginal bleeding, fetal compromise evidenced by nonreassuring fetal heart rate tracings, and abdominal pain from tetanic uterine contractions. Traditionally, the vaginal bleeding associated with placenta previa was described as painless, whereas that deriving from abruption of the placenta was characterized as painful. Although this differentiation may have been helpful in the past, contemporary obstetricians seldom need to rely only on this distinction, as ultrasound can, in most instances, quickly rule out the presence of a placenta previa. However, the magnitude of bleeding may not correlate with the degree of fetal or maternal compromise because of the location of the separation. In 10%­20% of the cases, placental abruption entails little or no vaginal bleeding, known as concealed abruption. This can also have devastating consequences as the reliance upon the magnitude of visible bleeding may lead to serious underestimation of the actual blood loss. It should be remembered in patients who present with abdominal pain without bleeding, other causes for the pain should be considered including nonobstetric causes of abdominal pain such as appendicitis, urinary tract infection, ovarian torsion, and degenerating fibroids. A conclusive prenatal diagnosis of abruption of the placenta is often difficult prior to delivery. Although an ultrasound examination is critical for ruling out abnormalities of placenta location, it is not a sensitive tool for diagnosing abruption. Since ultrasound examination may not reveal evidence of a retroplacental bleed, the differential diagnosis essentially rests upon sonographic exclusion of low implantation of the placenta and placenta previa. It is important to recognize that if changes are not seen by ultrasound, this does not exclude abruption. The sensitivity of the ultrasound examination may be as low as 24%, with a negative predictive value of 53%. On the other hand, specificity and positive predictive value are 96% and 88%, respectively. The presence of retroplacental hematoma is suggested by the finding on ultrasound examination of a thickened, heterogeneous placenta with rounded margins and intraplacental sonolucencies. The placenta may appear as much as 9 cm in thickness, compared with the normal 4­5 cm. However, it is not diagnostic and not helpful in guiding management, except for calculating dose of Rh-immune globulin required in a Rhesus-negative patient. A comparison of low-risk patients with those who experienced an abdominal trauma showed no difference in rate of positive tests. Small impressions are covered by firm clots, the extent of which provides a clue to the severity of the abruption. Pathologic examination shows clot on the maternal surface and may show compression of the tissue. The viability of the fetus at a given gestational age must be measured against the likely impact of the bleeding upon maternal and fetal well-being and the long-range outlook for the pregnancy in case expectant management is an option. Delays in diagnosis can be catastrophic and changes in fetal status can occur rapidly. Careful monitoring of maternal vital signs, urine output, electrolytes and acid­ base status, coagulation studies including fibrinogen are standard. Continuous fetal monitoring is initially required until the patient is deemed stable. Neonatology and anesthesia consultation is appropriate should delivery need to occur. When greater than 34 weeks gestation, patients with abruption should be delivered. Prior to 34 weeks gestation, expectant management is an option if the clinical condition of the patient is stable and bleeding has significantly decreased. Corticosteroids should be 232 Antepartum hemorrhage administered for fetal lung maturity. When the abruption is moderate, the associated fetal morbidity is usually due to the complications of prematurity. Given that the risks of prematurity are significant, tocolytics have been studied in stable patients and reported results do not suggest untoward effects to the mother or to the fetus. It should be kept in mind though that the evidence is retrospective and administration should be with caution. Women with vaginal bleeding or contractions after a motor vehicle accident or a direct abdominal trauma should generally be observed for at least 24 hours. Discharge after 6 hours has been found to be safe in the setting of blunt trauma when there is no evidence of compromise, contractions or fetal heart rate changes. By the 1980s, abdominal delivery was the treatment of choice in the United States. When the outlook for vaginal delivery is favorable and a trial of labor is decided upon, amniotomy may hasten delivery. After the abruption of the placenta, spontaneous onset of labor frequently ensues. The time interval between the occurrence of the abruption and delivery has considerable bearing upon the prospect of neonatal survival. It should be kept in mind that the time between the first appearance of fetal distress and in utero fetal demise may be short. Recurrent hemorrhage or sign of deterioration in the fetal condition requires delivery without delay as prolonged intervals to delivery are associated with poor outcomes. However, vigorous blood replacement is important when prompt surgical intervention is deemed necessary. In case of in utero fetal death, amniotomy can be performed followed by oxytocin stimulation. Hysterotomy may be still necessary, however, when the attempt is unsuccessful, insofar as both placental abruption and the presence of a dead fetus predispose to coagulation defects. When hemorrhage extends into the myometrium, termed the Couvelaire uterus, hysterectomy may be required in rare cases. The fibrinolytic system is activated leading to the production of fibrin split products. Damage occurs not only from blood loss but also as a result of hypoxia and tissue ischemia from fibrin plugs in the microvasculature. Although both are managed with the aggressive replacement of blood products, the inciting event must also be addressed. Timing of the delivery will be determined by whether the patient can deliver vaginally or if blood products can be given so that cesarean delivery can be performed as safely as possible. With administration of large amounts of crystalloids, a dilution coagulopathy could result, as well as third spacing and worsening of kidney injury, so in this setting transfusion of blood products should be considered early in the management and there is no reason for delaying resuscitation. It should be given when the prothrombin time and/or activated partial thromboplastin time values are more than 1. Institutional massive transfusion protocols allow for rapid preparation and administration of large volume of products and should be developed in collaboration with blood bank staff, anesthesiologists, and obstetricians. Platelet transfusion is indicated if the platelet count falls below 20,000, if operative intervention is planned and the platelet count is 50,000, or with massive hemorrhage. Cryoprecipitate is often given in case of declining fibrinogen levels out of proportion to other coagulation factors. Postpartum hemorrhage frequently follows delivery in connection with abruption of the placenta as a result of a clotting defect or uterine atony. On this account, routine Placenta previa 233 infusion of oxytocin during the third stage of labor is advisable. It is to be remembered that, once delivery has been effected and all products of conception have been removed from the uterus, spontaneous correction of the bleeding and clotting defects can be anticipated within hours. Prevention Prevention of placenta abruption includes discontinuation or reduction of smoking and avoidance of illicit drugs. Appropriate treatment of chronic hypertension and timely delivery in case of preeclampsia also reduce the risk of placental separation. It is important to use both shoulder and lap belts, with the latter applied low at the level of the pelvic bones. Although prior history of abruption increases the risk of this complication, no preventive intervention is currently recommended. Ultrasound examinations for fetal growth can be considered, but fetal surveillance is generally not warranted. Previously, previas have been categorized as central, partial, marginal, or low lying. With the use of transvaginal ultrasonography, the location of the placenta can be determined more accurately and so is called a previa if the placenta covers the internal os, and low lying, if the edge lies within 2 cm of the os. The placenta appears implanted over the lower segment with relative frequency on ultrasound examinations performed during the early second trimester. However, in about 90% of the instances, this is not demonstrated on follow-up ultrasound examinations. The apparent change in location is thought to be due to placental growth toward the area with greater blood supply. Additionally, as the uterus grows in size, the distance between the lower edge of the placenta and cervix also lengthens. Because of this, it is recommended to repeat the ultrasound examination in the early part of the third trimester (28­32 weeks) to reevaluate for placental location. A history of previous placenta previa, prior cesarean delivery or other prior uterine surgery, advanced maternal age, previous infertility, multiparity, smoking and history of a variety of reproductive abnormalities, as well as previous occurrence of low implantation, predispose to the occurrence of placenta previa. Whereas the major neonatal risks associated with placenta previa are associated with prematurity. In the past, on rare occasions, patients with placenta previa remained asymptomatic and thus undiagnosed, until the onset of labor at or near term. Placenta previa is to be included in the differential diagnosis whenever vaginal bleeding occurs during the second half of the pregnancy. If ultrasonography has not previously been performed and ruled out a placenta previa, this should be done before a pelvic examination is performed. Transabdominal sonography may quickly rule out a previa, as the site of the implantation of an anteriorly implanted placenta is easy to detect with ultrasound. But if the placenta appears close to the cervical os, transvaginal sonography should then be performed by an experienced sonographer, as this is more accurate. The exact localization of the posteriorly implanted placenta may also be difficult. Maternal obesity, distended bladder, and uterine activity may hinder the diagnosis in these cases. The visualization of the internal cervical os is facilitated by transvaginal sonography. In expert hands, such examination can be performed with relative ease without eliciting bleeding and has been found to be safe. Management As late as the mid-nineteenth century, the maternal mortality rate from placenta previa was about 25%. Irrespective of the method of delivery, the fetal mortality rate was almost 100% until the introduction of cesarean section into obstetric practice. By the turn of the twentieth century, cesarean section could be performed with relative safety by obstetric surgeons. As a result, the maternal mortality rate fell to 5% by the early 1900s, and the majority of babies could be delivered alive. By the 1920s, cesarean section was used liberally for the management of placenta previa.

Meclizine 25 mg buy mastercard. Bad Alternator Symptoms BMW 5 Series 3 Series E90 E39 528I 328I M5 M3.

Diseases

• Aagenaes syndrome
• Rayner Lampert Rennert syndrome
• Tracheobronchopathia osteoplastica
• Encephalopathy-basal ganglia-calcification
• Chromosome 2, monosomy 2p22
• Lucey Driscoll syndrome
• Primary malignant lymphoma

References

• Pickard R, Lam T, MacLennan G, et al: Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial, Lancet 380:1927-1935, 2012.
• Yasuda I, Tsurumi H, Omar S, et al. Endoscopic ultrasoundguided fine-needle aspiration biopsy for lymphadenopathy of unknown origin. Endoscopy. 2006;38:919-924.
• Louis DN. Molecular pathology of malignant gliomas. Annu Rev Pathol 2006;1:97-117.
• Prietsch V, Lindner M, Zschocke J, et al. Emergency management of inherited metabolic disease. J Inherit Metab Dis 2002;25:531.
• Nitti VW, Rovner ES, Bavendam T: Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity, BJU Int 105(9):1268n 1275, 2010.